NASDAQ

Insys Therapeutics Starts Enrollment in Cannabidiol Trial

//
Categories
Insys Therapeutics, Inc . INSY announced that it has enrolled the first patient in a phase II trial on its pharmaceutical cannabidiol (CBD) product candidate. The candidate is being evaluated for the treatment of cocaine dependence. The trial will determine the effects of CBD on the management of craving and withdrawal symptoms along with prevention...
Read More →

Analog Devices (ADI) Buys Cyber Security Unit of Sypris

//
Categories
Analog Devices, Inc. ADI has reportedly acquired the Cyber Security Solutions (CSS) business of Sypris Electronics LLC in an all cash deal worth $42 million.  What’s in Store for Analog Devices? This acquisition is expected to boost Analog Devices’ capabilities in the field of secure radio communications that has its application in the aerospace and...
Read More →

How Risky Is FireEye Inc Stock?

//
Categories
Image source: Getty Images. Cybersecurity specialist FireEye ‘s(NASDAQ: FEYE) stock is down sharply this year due to slowing sales growth and rising operating losses. The 30% year-to-date decline has lessened the risk for investors just by virtue of the bar being lowered for what might be considered a healthy rebound for the software company. However,...
Read More →

What Happened in the Stock Market Today

//
Categories
Stocks ended the trading week with minor losses despite a few surprisingly strong quarterly earnings announcements. On Friday, the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) indexes both fell slightly, leaving them unchanged over a week that was packed with earnings reports and a closely watched reading by the Federal...
Read More →